Dataset from ACCENT II - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long Term Treatment of Patients With Fistulizing CROHN'S Disease

Name: Dataset from ACCENT II - A Randomized, Double-blind, Placebo-controlled Trial of Anti-TNF Chimeric Monoclonal Antibody (Infliximab, Remicade) in the Long Term Treatment of Patients With Fistulizing CROHN'S Disease
Creator: 暂无描述
License: 暂无描述

NIAID Data Ecosystem2026-05-10 收录

下载链接：

https://doi.org/10.25934/00004623

下载链接

链接失效反馈

官方服务：

资源简介：

A study of infliximab in patients with Fistulizing Crohn's Disease

创建时间：

2026-01-07